Percutaneous coronary intervention
Transform complex PCI procedures into confident care
Demonstrated results in percutaneous coronary intervention
28.8%
reduction in contrast agent with Dynamic Coronary Roadmap1
Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.
Download85%
believe TSM control of HEMO visualizations improves workflow.2
A usability study revealed that 85% of users believe the Azurion TSM control of HEMO visualizations and measurements improves workflow.2 To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by 33 participants.
$896
saved per patient with Philips iFR compared to FFR.3
An analysis to assess a cost-minimization of iFR-guided compared with FFR-guided revascularization demonstrated a cost saving per patient of $681 (95% CI: $641 - $723) in the Nordic setting and $1024 (95% CI: $934 - $1114) in the US, when using iFR-guided revascularization.3
Stay close to the heart with Philips solutions
Efficiency in the cath lab
- Clearly identify coronary artery disease with imaging, physiology, co-registration and software available in one platform.
- Perform tasks such as 2D-QA during fluoroscopy or exposure with instant parallel working functionality.
- Make fast, informed clinical decisions by going beyond the angiogram to complete your view of the target vessel.
- Continuously monitor patients and improve cath lab workflows with hemo monitoring and data management.
Improve end-to-end experiences
- Easy access to applications and imaging tools to improve cath lab performance.
- Solutions for every step of coronary procedures, from diagnosis to restoring vessel patency.
- Scalable platform that will be ready to provide you with new innovations and tools as they become available in the future.
Featured solutions for percutaneous coronary intervention
Dynamic Coronary Roadmap is a great asset to add to the interventional toolkit. It is an easy-to-use tool which reduces the contrast exposure to patients. It is very useful in patients with low GFR or patients with branch vessel disease. I use it very frequently to assist in decreasing contrast use.
Enabling technologies
ClarityIQ technology delivers significantly lower dose across the clinical area, patients, and operators.
FlexArm ceiling-mounted system provides unlimited imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams.
Related procedures
Explore Philips’ TAVI and TAVR solutions, providing exceptional imaging and optimized processes for effective structural heart disease treatments.
Optimize LAAO procedures with Philips imaging technology, for precise device placement and streamlined workflows.
Elevate transcatheter mitral and tricuspid therapies with Philips imaging for accurate device placement and procedural efficiency.
When every moment counts, give them every chance with minimally invasive congenital heart disease interventions.
Improving patient care at Robert Bosch Hospital
See how Robert Bosch Hospital’s cardiac center implemented a multimodality imaging system, Philips Azurion with IntraSight, and enabled complex imaging.
- Clinical Study: Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4Contrast trial.
- Results obtained during usability study performed in December 2016. The study involved 33 participants. Participants were spread evenly over technologist/ nurses and physicians. To evaluate benefits of the multi-user capabilities of the new system design and user satisfaction, its novel design was tested by participants that had relevant working experience in the interventional lab and who had not previously used the new system. Data on File.
- Gotberg M, et al. Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis. Int J Cardiol 2021 1;344:54-59.
- Philips whitepaper 12nc 4522 991 30501; Reduction of procedure time by 17% with Philips Azurion in independently verified study; https://www.philips.com/healthcare/case-study/philips-azurion-lab-performance-study. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
- Co-registration tools available within InstraSight 7 configuration via SyncVision.